Results 161 to 170 of about 5,547 (244)

Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients.

JAMA Netw Open
Riegler JS, Kesselheim AS, Rome BN.
europepmc   +1 more source

Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process. [PDF]

Pharmaceuticals (Basel)
Shaifutdinov RR, Sinegubova MV, Vorobiev II, Prokhorova PE, Podkorytov AB, Orlova NA.   +5 more
europepmc   +1 more source

The Impact of U.S. Tariffs on the Pharmaceutical Industry and Medicine Access in Europe: Challenges, Opportunities, and Future Outlook. [PDF]

Hosp Pharm
Castellana E, Chiappetta MR.
europepmc   +1 more source

HASH(0x563d440b87b0) [PDF]

, 2007
Groth, S.
core  

Scientific Justification and Policy Recommendations to the US Food and Drug Administration for Waiving Comparative Efficacy Studies. [PDF]

Pharmaceuticals (Basel)
Niazi SK.
europepmc   +1 more source

Innovative Formulation Strategies for Biosimilars: Trends Focused on Buffer-Free Systems, Safety, Regulatory Alignment, and Intellectual Property Challenges. [PDF]

Pharmaceuticals (Basel)
Bas TG.
europepmc   +1 more source

Biosimilar insulins: Narrative review of the regulatory framework and registration studies. [PDF]

Diabetes Obes Metab
Heise T, DeVries JH.
europepmc   +1 more source

Scoping review of biosimilar disease-modifying antirheumatic drugs in pregnancy: evidence gaps and proposed outcome reporting framework. [PDF]

Rheumatol Int
Cheng V, Amiri N, Cheng V, Ellis U, Cragg JJ, Proulx L, Tucker DR, De Vera MA.   +7 more
europepmc   +1 more source

Assessing the Comparability of Degradation Profiles Between Biosimilar and Originator Anti-VEGF Monoclonal Antibodies Under Thermal Stress. [PDF]

Pharmaceuticals (Basel)
Pamukcu C, Atik AE.
europepmc   +1 more source

Substandard drugs: a potential crisis for public health [PDF]

, 2016
Abdullah MD, Akunyili D, Basco LK, Bate R, Caminero JA, Crevel R, El‐Duah M, Gostin LO, Homedes N, Iqbal M, Itah AY, Kenyon TA, Keoluangkhot V, Lambert PA, Laserson KF, Pillai G, Raufu A, Singh S, Tadeg H, Vijaykadga S   +19 more
core   +1 more source